Esperion Therapeutics (0ET.F) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.46
-0.2
0.06
0.32

Details

Expected EPS
-0.16226857032000003
Actual EPS
-0.1388715
Surprise EPS
0.02
Surprise Percent
+14.42%

Description

Esperion Therapeutics (0ET.F) has reported earnings of -0.1388715 per share for Q4 2024.

0 Comments

Share your thoughts